Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium.
Monitoring Natural SARS-CoV-2 Infection in Lions ( Panthera leo) at the Barcelona Zoo: Viral Dynamics and Host Responses
First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain.
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
Autoimmune B Cell Repertoire in a Mouse Model of Sjögren's Syndrome.
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus.
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
Anti-SARS-CoV-2 hyperimmune globulin demonstrates potent neutralization and antibody-dependent cellular cytotoxicity and phagocytosis through N and S proteins.